Clinical trial
Safety and Efficacy Study of a FAI Insert in Subjects With Chronic…
NCT02746991 · EyePoint Pharmaceuticals, Inc., Industry · Completed
Key facts
| NCT number | NCT02746991 |
|---|---|
| Title | Safety and Efficacy Study of a FAI Insert in Subjects With Chronic Non-infectious Posterior Uveitis |
| Official title | A Multi-center, Controlled, Safety and Efficacy Study of a Fluocinolone Acetonide Intravitreal (FAI) Insert in Subjects With Chronic Non-infectious Uveitis Affecting the Posterior Segment of the Eye |
| Lead sponsor | EyePoint Pharmaceuticals, Inc., Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Posterior Uveitis, Intermediate Uveitis, Panuveitis |
| Intervention type | Drug |
| Interventions | Sham Injection, FAI Insert |
| Enrollment | 153 |
| Start date | Jun 2, 2015 |
| Primary completion | Oct 4, 2019 |
| Completion | Oct 4, 2019 |
| First posted | Apr 21, 2016 |
| Last update posted | Jul 21, 2020 |
| Countries | India |
At a glance
- 10–99 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: